A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

IT’S a cruel disease that slowly steals the memories of it’s victims, eradicating precious moments before claiming life ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower blood ...

Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.

A groundbreaking analysis from leading British universities has uncovered surprising links between everyday medications and ...

The research indicated that those with cataracts and systemic conditions were up to 2.29 times more likely to develop ...

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

While memory loss is commonly associated with dementia, research from the University of Chicago suggests that a significant ...

Diabetes drug semaglutide linked to reduced risk of dementia in type 2 diabetes patients Effects strongest in women and older ...

A new study from UCLA Health has uncovered how inflammation in brain blood vessels exacerbates damage in vascular dementia ...